PRIVES LABORATORY
Selected landmark and recent work

Publications

Selected landmark and recent work

Explore landmark and current work spanning p53 DNA recognition, transcriptional context, MDM2 and MDMX regulation, mutant gain of function, tumour invasion, metabolism and therapeutic vulnerability.
2026

Genes & Development

Mutant p53: evolving perspectives

2025

Proceedings of the National Academy of Sciences

Mutant p53 regulates cancer cell invasion in complex three-dimensional environments through mevalonate pathway-dependent Rho/ROCK signaling

2025

Cancer Discovery

Mutant p53 Gain of Function: Why Many See It, Why Some Do Not

2025

Molecular Cell

A fork in the road: PADI4 citrullinates p53 to control immune-related networks

2024

Cell

p53: A tale of complexity and context

2024

Molecular Cancer Research

Systematic Characterization of p53-Regulated Long Noncoding RNAs across Human Cancers Reveals Remarkable Heterogeneity among Different Tumor Types

2023

Cancer Discovery

Li-Fraumeni Syndrome-Associated Dimer-Forming Mutant p53 Promotes Transactivation-Independent Mitochondrial Cell Death

2019

Cell

p53 Represses the Mevalonate Pathway to Mediate Tumor Suppression

2018

Genes & Development

Wild-type and cancer-related p53 proteins are preferentially degraded by MDM2 as dimers rather than tetramers

2015

Genes & Development

Mutant p53 cooperates with the SWI/SNF chromatin remodeling complex to regulate VEGFR2 in breast cancer cells

2015

Molecular and Cellular Biology

The p53 C terminus controls site-specific DNA binding and promotes structural changes within the central DNA binding domain

1991

Science

Identification of p53 as a sequence-specific DNA-binding protein